Dupilumab Delivers in Erythrodermic Atopic Dermatitis

(MedPage Today) -- Patients with severe erythrodermic atopic dermatitis (AD) had significant improvements with dupilumab (Dupixent) monotherapy or with concomitant topical corticosteroids, according to a post-hoc analysis of six randomized trials...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news